MB Diagnostics ApS: Financial statements 2025
CVR: 38185853
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
MB Diagnostics ApS (CVR 38185853) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -11,000 and a net result of DKK -23,026 compared with DKK -15,293 the year before. Equity in the 2025 report amounted to DKK 566,629. The solvency ratio was 53.1%.
- Gross Profit
- DKK -11,000
- Profit/Loss
- DKK -23,026
- Equity
- DKK 566,629
- Total Assets
- DKK 1,066,563
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -11 t. | -23 t. | 567 t. | 0 |
| 2024 | - | -2 t. | -15 t. | 590 t. | 0 |
| 2023 | - | 30 t. | 10 t. | 605 t. | 0 |
| 2022 | - | 15 t. | -2 t. | 713 t. | 0 |
| 2021 | - | 43 t. | 22 t. | 828 t. | 0 |
Official annual report
How creditworthy is MB Diagnostics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
MB Diagnostics ApS has published its annual report for 2024. Gross profit came to DKK -2,275, and the net result was DKK -15,293.
About MB Diagnostics ApS
MB Diagnostics ApS is a Danish company of the type Anpartsselskab based in Nærum, founded in 2016. The company is registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The management consists of Mikael Ploug Boesen. The company is owned by Mikael Ploug Boesen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,000 and a net result of DKK -23,026 compared with DKK -15,293 the year before. Equity in the 2025 report amounted to DKK 566,629.